Phase I combining a P-glycoprotein inhibitor, MS209, in combination with docetaxel in patients with advanced malignancies.

Source:http://linkedlifedata.com/resource/pubmed/id/16144929

Clin. Cancer Res. 2005 Sep 1 11 17 6256-60

Download in:

View as

Triples

General Info

PMID
16144929